Skip to main content
Log in

Percutaneous MR-guided cryoablation of prostate cancer: initial experience

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

We report our initial experience and the technical feasibility of transperineal prostate cryoablation under MR guidance.

Methods

Percutaneous MR-guided cryoablation was performed in 11 patients with prostatic adenocarcinoma contraindicated for surgery (mean age: 72 years, mean Gleason score: 6.45, mean prostate-specific antigen (PSA): 6.21 ng/ml, T1-2c/N0/M0, mean: prostate volume 36.44 ml). Free-hand probe positioning was performed under real-time MR imaging. Four to seven cryoprobes were inserted into the prostate, depending on gland volume. The ice ball was monitored using real-time and high-resolution BLADE multi-planar imaging. Patients were followed at 1, 3, 6, 9 and 12 months after the procedure with serum PSA level and post-ablation MRI.

Results

Prostate cryoablation was technically feasible in 10/11 patients. The ice ball was clearly and sharply visualised in all cases as a signal-void area. Mean ice-ball volume was 53.3 ml. Mean follow-up was 15 months (range: 1–25). Mean PSA nadir was 0.33 ng/ml (range: 0.02–0.94 ng/ml). Mean hospitalisation was 5 days (range: 3–13). Complications included a urethro-rectal fistula, urinary infection, transient dysuria and scrotal pain.

Conclusions

MR-guided prostate cryoablation is feasible and promising, with excellent monitoring of the ice ball. Future perspectives could include the use of MR guidance for focal prostate cancer cryotherapy.

Key Points

Magnetic resonance allows precise positioning of cryoprobes with real-time imaging.

High-resolution MRI allows excellent monitoring of the developing ice ball.

Cryoablation of prostate cancer under MR guidance is technically feasible.

Further work will refine the procedure and make it even safer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592

    Article  PubMed  CAS  Google Scholar 

  2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  3. Ataman F, Zurlo A, Artignan X et al (2004) Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863. Eur J Cancer 40:1674–1681

    Article  PubMed  Google Scholar 

  4. Potosky AL, Legler J, Albertsen PC et al (2000) Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcome Study. J Natl Cancer Inst 92:1582–1592

    Article  PubMed  CAS  Google Scholar 

  5. Heidenreich A, Bolla M, Joniau S et al (2011) Guidelines on Prostate Cancer. European Association of Urology. www.uroweb.org

  6. Gonder MJ, Soanes WA, Shulman S (1966) Cryosurgical treatment of the prostate. Invest Urol 3:372–378

    PubMed  CAS  Google Scholar 

  7. Ghafar MA, Johnson CW, De La Taille A et al (2001) Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 166:1333–1337, discussion 1337–1338

    Article  PubMed  CAS  Google Scholar 

  8. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72:1291–1299

    Article  PubMed  CAS  Google Scholar 

  9. Onik G (2007) Percutaneous image-guided prostate cancer treatment: cryoablation as a successful example. Tech Vasc Interv Radiol 10:149–158

    Article  PubMed  Google Scholar 

  10. Cohen JK, Miller RJ, Shuman BA (1995) Urethral warming catheter for use during cryoablation of the prostate. Urology 45:861–864

    Article  PubMed  CAS  Google Scholar 

  11. Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS (2001) Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template-technique and preliminary results. Urology 58:988–993

    Article  PubMed  CAS  Google Scholar 

  12. Pisters LL, von Eschenbach AC, Scott SM et al (1997) The efficacy and complications of salvage cryotherapy of the prostate. J Urol 157:921–925

    Article  PubMed  CAS  Google Scholar 

  13. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr (2001) Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 57:518–523

    Article  PubMed  CAS  Google Scholar 

  14. Donnelly BJ, Saliken JC, Ernst DS et al (2002) Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 60:645–649

    Article  PubMed  CAS  Google Scholar 

  15. Han KR, Cohen JK, Miller RJ et al (2003) Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170:1126–1130

    Article  PubMed  Google Scholar 

  16. Cohen JK, Miller RJ Jr, Ahmed S, Lotz MJ, Baust J (2008) Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 71:515–518

    Article  PubMed  Google Scholar 

  17. Leibovici D, Zisman A, Siegel YI, Lindner A (2001) Cryosurgical ablation for prostate cancer: preliminary results of a new advanced tecnhique. IMAJ 3:484–487

    PubMed  CAS  Google Scholar 

  18. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V (2007) Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology 70:117–121

    Article  PubMed  Google Scholar 

  19. Mazaheri Y, Shukla-Dave A, Hricak H et al (2008) Prostate cancer: identification with combined diffusion-weighted MR imaging and 3-D 1H spectroscopic imaging—correlation with pathologic findings. Radiology 246:480–488

    Article  PubMed  Google Scholar 

  20. Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167

    Article  PubMed  Google Scholar 

  21. Franiel T, Hamm B, Hricak H (2011) Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 21:616–626

    Article  PubMed  Google Scholar 

  22. Heijmink SW, Futterer JJ, Strum SS et al (2011) State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer. Acta Oncol 50:25–38

    Article  PubMed  Google Scholar 

  23. Silverman SG, Tuncali K, vanSonnenberg E et al (2005) Renal tumors: MR imaging-guided percutaneous cryotherapy—initial experience in 23 patients. Radiology 236:716–724

    Article  PubMed  Google Scholar 

  24. Chen X, Barkauskas KJ, Nour SG, Duerk JL, Abdul-Karim FW, Saidel GM (2007) Magnetic resonance imaging and model prediction for thermal ablation of tissue. J Magn Reson Imaging 26:123–132

    Article  PubMed  Google Scholar 

  25. Theodorescu D (2004) Cancer cryotherapy: evolution and biology. Rev Urol 6:S9–S19

    PubMed  Google Scholar 

  26. Saliken JC, Donnelly BJ, Rewcastle JC (2002) The evolution and state of modern technology foe prostate cryosurgery. Urology 60:26–33

    Article  PubMed  Google Scholar 

  27. Lu A, Daniel BL, Kaye E, Butts-Pauly K (2011) MRI of frozen tissue demonstrates a phase shift. Magn Reson Med 66:1582–1589

    Article  PubMed  Google Scholar 

  28. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB (2001) Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165:1937–1941, discussion 1941–1932

    Article  PubMed  CAS  Google Scholar 

  29. Donnelly BJ, Saliken JC, Ernst DS et al (2005) Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy. Prostate Cancer Prostatic Dis 8:235–242

    Article  PubMed  CAS  Google Scholar 

  30. Han KR, Belldegrun AS (2004) Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 93:14–18

    Article  PubMed  Google Scholar 

  31. Ahmed HU, Freeman A, Kirkham A et al (2011) Focal therapy for localized prostate cancer: a phase I/II trial. J Urol 185:1246–1254

    Article  PubMed  CAS  Google Scholar 

  32. Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J (2008) The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 26:500–505

    Article  PubMed  Google Scholar 

  33. de la Rosette J, Ahmed H, Barentsz J et al (2010) Focal therapy in prostate cancer—report from a consensus panel. J Endourol 24:775–780

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Afshin Gangi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gangi, A., Tsoumakidou, G., Abdelli, O. et al. Percutaneous MR-guided cryoablation of prostate cancer: initial experience. Eur Radiol 22, 1829–1835 (2012). https://doi.org/10.1007/s00330-012-2411-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-012-2411-8

Keywords

Navigation